A second double-blind, active comparator-controlled extension of a placebo-controlled, double-blind study to assess safety and further define the clinically effective dose range of MK-0966 in patients with osteoarthritis of the knee or hip. Protocol 029-20,
Role: PI,
Merck, Sharp, and Dohme (MSD) Research Foundation,
(03/1999 - 03/2000)
Status: Completed
A third double-blind, active comparator-controlled extension of a placebo-controlled, double-blind study to assess safety and further define the clinically effective dose range of MK-0966 in patients with osteoarthritis of the knee or hip,
Role: PI,
Merck, Sharp, and Dohme (MSD) Research Foundation,
(09/1998 - 09/1999)
Status: Completed
Internal
Integrative medical care study - phase 2,
Role: Investigator,
LLU Dept. of Medicine,
(04/2000)
Status: Completed
Integrative Medical Care,
Role: Investigator,
LLU Dept. of Medicine,
(06/1998 - 05/1999)
Status: Completed
Other Research
Co-Investigator: Integrative medical Care Study-Phase 2. April 2000.
(04/2000)
Co-Investigator: Prayer Study: Integrative Medical Care. 1997-1999.
(1997 - 1999)
Co-Investigator: Medical education research around the LLU Graduate Medical Education Core Curriculum Projects, Fall 2007 to present.
(09/2007 - Present)